TRIPPPL

Recapitalising UK plc by helping world-leading businesses of tomorrow scale and grow. Alternative, affordable funding route for high growth companies with highly automated IPO and reporting processes for reduced cost and time burdens. Patient capital alternative to venture capital and private equity: no loss of control; no 3-5-year exit target; no pressure to financially engineer the business or load with debt. Democratised investing with unique investment opportunities for institutional and retail investors; enhanced investor insight, due-diligence and decision-making through evidence-based, corporate, ESG and financial reporting. Financial Conduct Authority licensed and regulated (at launch).